Clinical trial of fusidic acid for lepromatous leprosy.

Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Franzblau, S G, Chan, G P, Garcia-Ignacio, B G, Chavez, V E, Livelo, J B, Jimenez, C L, Parrilla, M L, Calvo, R F, Williams, D L, Gillis, T P
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 1994
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284609/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7979302/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.7.1651
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados